Fondaparinux Sodium 55150-0233
Product NDC
55150-0233- Manufacturer
- Eugia Us Llc
- Dosage Form
- Injection, Solution
- Route
- Subcutaneous
- Product Type
- Human Prescription Drug
- Marketing Start
- December 26, 2017
- Listing Expires
- December 31, 2026
- Application
- ANDA206918
Need to source Fondaparinux Sodium? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Fondaparinux Sodium | 10 mg/.8mL |
Drug Class
Factor Xa Inhibitor [EPC]Factor Xa Inhibitors [MoA]
Packaging Options(2)
2 SYRINGE, GLASS in 1 CARTON (55150-233-02) / .8 mL in 1 SYRINGE, GLASS (55150-233-00)
10 SYRINGE, GLASS in 1 CARTON (55150-233-10) / .8 mL in 1 SYRINGE, GLASS (55150-233-00)